IN2014DN06920A - - Google Patents

Info

Publication number
IN2014DN06920A
IN2014DN06920A IN6920DEN2014A IN2014DN06920A IN 2014DN06920 A IN2014DN06920 A IN 2014DN06920A IN 6920DEN2014 A IN6920DEN2014 A IN 6920DEN2014A IN 2014DN06920 A IN2014DN06920 A IN 2014DN06920A
Authority
IN
India
Prior art keywords
cell
recombinant
coli nissle
directed
ecn
Prior art date
Application number
Other languages
English (en)
Inventor
Tobias ÖLSCHLÄGER
Ean Jeong Seo
Jan Wehkamp
Eduard F Stange
Ulrich Sonnenborn
Jürgen Malinka
Hans Proppert
Original Assignee
Pharma Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Zentrale Gmbh filed Critical Pharma Zentrale Gmbh
Publication of IN2014DN06920A publication Critical patent/IN2014DN06920A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN6920DEN2014 2012-02-17 2013-02-14 IN2014DN06920A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12001091.3A EP2628793A1 (en) 2012-02-17 2012-02-17 Recombinant escherichia coli strains
PCT/EP2013/000446 WO2013120618A1 (en) 2012-02-17 2013-02-14 Recombinant escherichia coli strains

Publications (1)

Publication Number Publication Date
IN2014DN06920A true IN2014DN06920A (ko) 2015-04-10

Family

ID=47843228

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6920DEN2014 IN2014DN06920A (ko) 2012-02-17 2013-02-14

Country Status (9)

Country Link
US (1) US20160015781A1 (ko)
EP (1) EP2628793A1 (ko)
CN (1) CN104126003A (ko)
AU (1) AU2013220738A1 (ko)
CA (1) CA2864870A1 (ko)
EA (1) EA201491513A1 (ko)
HK (1) HK1199060A1 (ko)
IN (1) IN2014DN06920A (ko)
WO (1) WO2013120618A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110914386A (zh) * 2017-06-12 2020-03-24 杜克大学 用于生产生物分子的组合物、系统和方法
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
US10485632B1 (en) 2018-11-27 2019-11-26 King Saud University Intraoral attachment clip for attachment of objects to edentulous ridges
KR20210125992A (ko) * 2019-02-15 2021-10-19 온코시미스 바이오테크 프라이빗 리미티드 향상된 단백질 분비를 위한 박테리아 발현 벡터
US12011466B2 (en) * 2019-07-08 2024-06-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Modified Escherichia coli strain Nissle and treatment of gastrointestinal disorder
WO2022067219A1 (en) * 2020-09-28 2022-03-31 The Regents Of The University Of Michigan Methods and compositions for intestinal inflammation
CN115521884B (zh) * 2022-07-20 2023-12-29 四川宏展致远环保科技有限公司 一种类芽孢杆菌hnp12及其应用
CN116496916A (zh) * 2022-12-27 2023-07-28 安徽斯拜科生物科技有限公司 一种高产hbd-2的毕赤酵母工程菌株及其制备方法和应用
CN116769814B (zh) * 2023-06-16 2024-02-02 苏州泓迅生物科技股份有限公司 一种大肠杆菌益生菌t7表达系统及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102264905A (zh) * 2008-10-30 2011-11-30 基因桥有限责任公司 用于多肽重组表达的基于t7双启动子的载体系统

Also Published As

Publication number Publication date
US20160015781A1 (en) 2016-01-21
HK1199060A1 (en) 2015-06-19
CA2864870A1 (en) 2013-08-22
WO2013120618A1 (en) 2013-08-22
EP2628793A1 (en) 2013-08-21
AU2013220738A9 (en) 2014-10-16
AU2013220738A1 (en) 2014-09-04
EA201491513A1 (ru) 2015-01-30
CN104126003A (zh) 2014-10-29

Similar Documents

Publication Publication Date Title
IN2014DN06920A (ko)
IN2014DN05670A (ko)
MX2019011215A (es) Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
TR201900649T4 (tr) Oküler hastalıkların tedavisi için mrna tedavisi.
MX2019000586A (es) Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd).
UA117103C2 (uk) Сполука, яка має активність агоніста глюкагону
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
SG10201907775QA (en) Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
MX2013006040A (es) Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis.
MX341324B (es) Polipeptidos.
GB2496337A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
NZ703597A (en) Mutant fragments of ospa and methods and uses relating thereto
MX2013001677A (es) Formulaciones estables de linaclotida.
MX2014004814A (es) Compuestos y metodos para mejorar las respuestas inmunes innatas.
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
PH12014501388A1 (en) A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
MX2015011846A (es) Proteinas de sustancia de inhibicion mulleriana (mis) modificadas y sus usos para el tratamiento de enfermedades.
EP3747457A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
PH12015502500B1 (en) Bacteriophage therapy
MX2014004953A (es) Ligadores basados en tirosina para la conexion desprendible de peptidos.
GEP201606514B (en) Apoptosis inhibitors and usage thereof
WO2013173827A3 (en) Methods and compositions for inhibiting diseases of the central nervous system